Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2025-04-30 Report Publication Anno…
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
FORM 20-F For the fiscal year ended December 31, 2024
Report Publication Announcement Classification · 100% confidence The document is a short regulatory filing (1826 characters) from XTL Biopharmaceuticals Ltd submitted via the Israel Securities Authority's MAGNA system. It explicitly states 'Attached hereto is a report on...' followed by a filename (ea023966101_20f_xtlbio_bannerless_isa.pdf). Per the 'Menu vs Meal' rule, since this is a short announcement notifying the public of the availability of an attached report (a 20-F filing), it is classified as a Report Publication Announcement.
2025-04-30 English
ANNUAL REPORT
Annual Report FY 2024
2025-04-30 English
Noam Band was appointed the Chief Executive Officer, Mr. Band replaces Shlomo Shalev who will continue to serve as the Chairman of the Company’s Board of Directors
Board/Management Information Classification · 98% confidence The document is explicitly titled "Form 6-K, Report of Foreign Private Issuer" filed with the SEC. The content details the appointment of a new Chief Executive Officer (Noam Band) and includes a furnished press release announcing this management change. This type of filing, reporting material events for a foreign private issuer, often covers significant corporate governance or management changes. The specific event described—the appointment of a new CEO—directly corresponds to the definition of Board/Management Information (MANG). While Form 6-K is a general SEC filing category, the substance of the report points specifically to MANG.
2025-04-07 English
Noam Band was appointed the Chief Executive Officer, Mr. Band replaces Shlomo Shalev who will continue to serve as the Chairman of the Company’s Board of Directors
Report Publication Announcement Classification · 98% confidence The document is an 'Immediate Report' filed under Israeli regulations ('Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000') and mentions reporting to the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE), while also noting it is a foreign private issuer reporting to NASDAQ CM. Crucially, the text states: 'Attached hereto is a report on*...ea023731101_6k_xtlbioEDGAR3_Bannerless_isa.pdf*'. The presence of '_6k_' in the attached filename strongly suggests the underlying document is a Form 6-K, which is the SEC equivalent for foreign private issuers reporting material events. Since this document is merely announcing the attachment/publication of the main report (and is very short, 1831 chars), it fits the definition of a Report Publication Announcement (RPA) rather than the full report itself (which would likely be classified as 10-K if it were a full annual report, or RNS/IR if it were a quarterly report, but RPA is best for the announcement wrapper). Given the context of a foreign issuer reporting material information, and the document being an announcement wrapper, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule.
2025-04-07 English
REPORT OF FOREIGN PRIVATE ISSUER
Board/Management Information Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. The content primarily announces the appointment of a new Chief Executive Officer, Noam Band, replacing the previous CEO. It includes biographical details and mentions a press release attached as Exhibit 99.1. The document does not contain financial statements, audit information, or detailed financial analysis. It is an announcement of a management change rather than a full management report or annual/interim report. Therefore, it fits the category of Board/Management Information (MANG). The document length is 2623 characters, which is relatively short and consistent with an announcement rather than a full report. Hence, the classification is MANG with high confidence.
2025-04-07 English
Definitive Exclusive Sublicense Agreement with Biossil, a company incorporated under the laws of Canada
Regulatory Filings Classification · 95% confidence The document is explicitly titled "Form 6-K" and is filed by a "Foreign Private Issuer" with the SEC. Form 6-K is used to report material information that a foreign private issuer is required to disclose to its home country's securities regulator or stock exchange, or that it makes public in its home country. This type of filing is generally used for current material events, similar to an 8-K in the US system. Since the definitions provided do not include a specific code for Form 6-K, and the content details a significant corporate event (a definitive Exclusive Sublicense Agreement), it must be classified under the most appropriate general category. The content is a material announcement, not a full annual report (10-K), an earnings release (ER), or a management discussion (MDA). Given the options, the most suitable fallback category for a significant, non-standard regulatory disclosure that isn't explicitly covered by other specific codes (like M&A, CAP, DIV, etc.) is 'Regulatory Filings' (RNS), as 6-K is a standard SEC filing form for foreign issuers reporting material events.
2025-03-04 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.